A Phenomics Australia case study
Multidrug-resistant bacteria are a leading public health threat. With the help of the Phenomics Australia Histopathology and Slide Scanning Service, researchers have identified a new antibiotic to target these bacteria. The drug candidate is being tested in a clinical trial. Read the full article here.
New antibiotic candidate to tackle deadly bacterial ‘superbugs’. Link here.
Antibiotic resistance is threatening our health. Will bacterial infection send us back to the medical dark age? Link here.
New antibiotic to combat deadly bacterial ‘superbugs’ enters clinical trials. Link here.
Monash Biomedicine Discovery Institute. Link here.
Qpex Biopharma. Link here.
Identifying a new polymyxin for antibiotic drug development. Link here.